Trials & R&D · first seen 23 Sep, updated 23 Sep
Roche Drug Candidate Hits Target in Late-Stage Study for Autoimmune Disease
The company said it would share the study’s interim data with health authorities with the aim of bringing the treatment to the market as soon as possible.
Summary from WSJ - Health.